Lineage Cell Therapeutics, Inc. (LCTX) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 19 Form 4 transactions for Lineage Cell Therapeutics, Inc. (LCTX) over the past 18 months (most recent 2026-03-12). Recent activity: Culley Brian M (President and CEO) Buy 15,000 shares, Samuel George A. III (General Counsel and Secretary) Buy 6,075 shares, Samuel George A. III (General Counsel and Secretary) Sell 2,502 shares, Culley Brian M (President and CEO) Buy 31,250 shares, Culley Brian M (President and CEO) Sell 12,869 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-03-12Culley Brian MPresident and CEOBuy15,000$24,450
2026-02-13Samuel George A. IIIGeneral Counsel and SecretaryBuy6,075$0
2026-02-13Samuel George A. IIIGeneral Counsel and SecretarySell2,502$4,504
2026-02-13Culley Brian MPresident and CEOBuy31,250$0
2026-02-13Culley Brian MPresident and CEOSell12,869$23,164
2025-12-19Samuel George A. IIIGeneral Counsel and SecretaryBuy1,735$0
2025-12-19Samuel George A. IIIGeneral Counsel and SecretarySell65$109
2025-12-19Culley Brian MPresident and CEOBuy8,925$0
2025-12-19Culley Brian MPresident and CEOSell334$561
2025-02-12Samuel George A. IIIGeneral CounselBuy6,076$0
2025-02-12Samuel George A. IIIGeneral CounselSell2,440$1,586
2025-02-12Culley Brian MPresident and CEOBuy31,249$0
2025-02-12Culley Brian MPresident and CEOSell12,547$8,156
2025-01-28BROADWOOD PARTNERS, L.P.DirectorBuy7.9M$6.0M
2025-01-28BROADWOOD CAPITAL INCInsiderBuy7.9M$6.0M
2025-01-28BRADSHER NEAL CDirectorBuy7.9M$6.0M
2025-01-28BROADWOOD PARTNERS, L.P.DirectorBuy0$0
2025-01-28BROADWOOD CAPITAL INCInsiderBuy0$0
2025-01-28BRADSHER NEAL CDirectorBuy0$0

Source: SEC Form 4 filings · as of 2026-03-12